A list of 19 772 registrations (covering approximately 2 700 unique substances) provides the baseline against which the 5% compliance checks (989 CCHs) to be concluded by end of 2013 is calculated.
|Type of concluded Compliance Checks||Total|
| Total number of concluded |
*The total is higher than 989 because ECHA has performed more targeted CCHs than originally planned
Table 3.1: Concluded CCHs considered as contributing to the 5% target
The concluded CCHs have addressed approximately 957 unique substances. ECHA has therefore concluded an overall or targeted CCH on approximately 35% of the 2010 phase-in substances. From the substances covered by standard registration (i.e. substances with intermediate use only excluded), ca. 45% have been subject to a compliance check.
Over this period ECHA has also undertaken over 400 compliance checks that do not contribute to the 5% target and which are not included into these statistics.
GRAPH 1 – indicating the dossiers checked for compliance and contributing to the 5% target.
69% of the evaluated dossiers resulted in a draft decision requiring more information to be sent to the registrant. The main reasons and findings why draft decisions were sent to the registrants can be found in the evaluation reports and in the public versions of the decisions. ECHA highly encourages registrants to use these as information sources to proactively improve their dossiers.
|Concluded CCH||Total cumulative||2009||2010||2011||2012||2013||%|
|Concluded without regulatory action||349||0||4||12||97||236||31%|
Table 3.2: Summary of all concluded compliance checks performed from January 2009 to December 2013 and the types of conclusion.